SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-029435
Filing Date
2020-03-05
Accepted
2020-03-05 07:05:30
Documents
3
Period of Report
2020-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2011781-1_8k.htm 8-K 21516
2 EXHIBIT 99.1 tm2011781d1_99-1.htm EX-99.1 11515
3 GRAPHIC tm2011781d1_99-1img001.jpg GRAPHIC 3627
  Complete submission text file 0001104659-20-029435.txt   39420
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 20689615
SIC: 2834 Pharmaceutical Preparations